Form 4: Gossamer Bio Director Acquires 115,000 Stock Options

Director Thomas O. Daniel acquired 115,000 non-qualified stock options in Gossamer Bio, Inc. on June 6, 2024, as part of the Non-Employee Director Compensation Program.

Summary

• Thomas O. Daniel, a director of Gossamer Bio, Inc., acquired 115,000 non-qualified stock options on June 6, 2024.
• The options were granted as part of the Non-Employee Director Compensation Program.
• The exercise price of the options is $0.60.
• The options vest on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, contingent upon continued service on the board.
• The options expire on June 5, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options to a director is a common practice and suggests alignment of interests with shareholders. There are no immediate negative implications.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the options is contingent upon the director's continued service on the board, aligning their interests with the long-term success of the company.

Industry Context

Stock option grants are a common form of compensation for directors, particularly in biotech companies, to incentivize performance and align interests with shareholders.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary significantly across the biotech industry depending on company size, stage of development, and board responsibilities.
• Comparing Gossamer Bio's director compensation to peers like Arcus Biosciences or Iovance Biotherapeutics would provide a better understanding of whether the option grant is within industry norms.

Stakeholder Impact

• The granting of stock options aligns the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates